Teladoc Health, Inc. (TDOC): R&D Expense
$277.92M
Year ended 2025-12-31
$269.91M
Trailing 12 months to 2026-06-30
-5.9%
3-year compound annual growth
+11.0%
5-year compound annual growth
+34.6%
10-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $277.92M | -9.6% | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | $307.27M | -11.8% | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | $348.52M | +4.5% | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | $333.63M | +7.0% | 2025-02-27, From 2022-01-01 |
| 2021-12-31 | $311.88M | +89.1% | 2024-02-23, From 2021-01-01 |
| 2020-12-31 | $164.94M | +155.2% | 2023-03-01, From 2020-01-01 |
| 2019-12-31 | $64.64M | +18.9% | 2022-02-28, From 2019-01-01 |
| 2018-12-31 | $54.37M | +57.8% | 2021-03-01, From 2018-01-01 |
| 2017-12-31 | $34.46M | +58.0% | 2020-02-26, From 2017-01-01 |
| 2016-12-31 | $21.82M | +53.5% | 2019-02-27, From 2016-01-01 |
| 2015-12-31 | $14.21M | +87.6% | 2018-02-27, From 2015-01-01 |
| 2014-12-31 | $7.57M | +114.4% | 2017-03-01, From 2014-01-01 |
| 2013-12-31 | $3.53M | n/a | 2016-03-03, From 2013-01-01 |